Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.92 USD | +5.81% | +8.61% | +86.02% |
05-07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
05-01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+86.02% | 3.26B | |
+5.08% | 109B | |
+11.59% | 105B | |
+0.09% | 22.25B | |
-12.26% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.05% | 16.85B | |
+4.75% | 13.76B | |
+34.95% | 12.46B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Summit Therapeutics Insider Bought Shares Worth $4,999,999, According to a Recent SEC Filing